Abstract
Acquired aplastic anaemia (aAA) is recognized as an autoimmune disorder; however, the autoantigens and target cells involved remain elusive. Expression of autoantibodies and their target cells were examined using the haematopoietic cell line K562 and bone marrow stromal cell line hTS-5; 43·5% and 21·7% of aAA expressed autoantibody against K562 and hTS-5 cells, respectively. The autoantigens were identified by serological identification of antigens through recombinant cDNA expression cloning. This study indicates that haematopoietic cells are the targets of immune abnormality in aAA. These autoantibodies may be utilized to distinguish patients associated with immune abnormality from bone marrow failure syndrome. © 2012 Blackwell Publishing Ltd.
Author supplied keywords
Cite
CITATION STYLE
Goto, M., Kuribayashi, K., Takahashi, Y., Kondoh, T., Tanaka, M., Kobayashi, D., & Watanabe, N. (2013). Identification of autoantibodies expressed in acquired aplastic anaemia. British Journal of Haematology, 160(3), 359–362. https://doi.org/10.1111/bjh.12116
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.